Overview

Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C

Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the safety and efficacy of AL-59412C injected intravitreally relative to Vehicle.
Phase:
Phase 2
Details
Lead Sponsor:
Alcon Research
Treatments:
Pharmaceutical Solutions
Travoprost